Daewoong Pharmaceutical confirms the treatment effect of COVID-19 in Hoystar tablet ‘2a clinical trial’
Daewoong Pharmaceutical confirms the effect of Hoystar tablet COVID-19 treatment in Phase 2a clinical trial
Daewoong Pharmaceutical’s’Hoystar tablet’ confirmed the possibility of COVID-19 treatment in phase 2a clinical trial
![[SEN]C&Pharm develops injections for severely ill patients with COVID-19](https://img.sedaily.com/web/common/sedaily.jpg "[SEN]C&Pharm develops injections for severely ill patients with COVID-19")
